NIM
NEOS Investment Management Portfolio holdings
AUM
$8.08B
This Quarter Return
+5.84%
1 Year Return
+24.46%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.31B
AUM Growth
+$3.31B
(+36%)
Cap. Flow
+$835M
Cap. Flow
% of AUM
25.23%
Top 10 Holdings %
Top 10 Hldgs %
34.05%
Holding
588
New
19
Increased
514
Reduced
16
Closed
9
Top Buys
| 1 |
Broadcom
AVGO
|
$67.9M |
| 2 |
Vanguard Russell 2000 ETF
VTWO
|
$64.4M |
| 3 |
Apple
AAPL
|
$36.2M |
| 4 |
Microsoft
MSFT
|
$35.6M |
| 5 |
NVIDIA
NVDA
|
$34.7M |
Top Sells
| 1 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$1.21M |
| 2 |
Super Micro Computer
SMCI
|
$812K |
| 3 |
Exelixis
EXEL
|
$572K |
| 4 |
MREO
Mereo BioPharma
MREO
|
$511K |
| 5 |
Vale
VALE
|
$440K |
Sector Composition
| 1 | Technology | 32.75% |
| 2 | Healthcare | 12.38% |
| 3 | Communication Services | 9.77% |
| 4 | Consumer Discretionary | 9.17% |
| 5 | Industrials | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
501
Teva Pharmaceuticals
TEVA
$21.5B
| $462K | 0.01% |
25,662
+1,873
| +8% | +$33.8K |
|
502
Bunge Global
BG
$16.3B
| $462K | 0.01% |
4,779
+812
| +20% | +$78.5K |
|
|
VERV
503
DELISTED
Verve Therapeutics
VERV
| $460K | 0.01% |
95,029
+7,334
| +8% | +$35.5K |
|
504
IDEAYA Biosciences
IDYA
$2.23B
| $459K | 0.01% |
14,489
+4,335
| +43% | +$137K |
|
505
Match Group
MTCH
$8.9B
| $454K | 0.01% |
12,011
+2,436
| +25% | +$92.2K |
|
506
Mettler-Toledo International
MTD
$26.3B
| $454K | 0.01% |
303
| – | – |
|
507
Neurocrine Biosciences
NBIX
$14.1B
| $443K | 0.01% |
3,846
+294
| +8% | +$33.9K |
|
508
Rollins
ROL
$27.5B
| $440K | 0.01% |
8,700
+1,624
| +23% | +$82.1K |
|
509
News Corp Class A
NWSA
$16.3B
| $434K | 0.01% |
16,283
+3,248
| +25% | +$86.5K |
|
510
Cullinan Oncology
CGEM
$442M
| $429K | 0.01% |
25,640
+1,617
| +7% | +$27.1K |
|
511
Norwegian Cruise Line
NCLH
$11.2B
| $428K | 0.01% |
20,860
+5,241
| +34% | +$107K |
|
|
SW
512
Smurfit Westrock plc
SW
$24.6B
| $428K | 0.01% |
+8,655
| New | +$428K |
|
513
CF Industries
CF
$14.2B
| $415K | 0.01% |
4,838
+812
| +20% | +$69.7K |
|
514
Albemarle
ALB
$9.36B
| $414K | 0.01% |
4,370
+812
| +23% | +$76.9K |
|
515
Relay Therapeutics
RLAY
$631M
| $413K | 0.01% |
58,290
+3,685
| +7% | +$26.1K |
|
516
Arvinas
ARVN
$580M
| $413K | 0.01% |
16,750
-3,282
| -16% | -$80.8K |
|
517
Tapestry
TPR
$21.4B
| $408K | 0.01% |
8,688
+1,624
| +23% | +$76.3K |
|
518
NVR
NVR
$22.6B
| $402K | 0.01% |
41
| – | – |
|
|
BCYC
519
Bicycle Therapeutics
BCYC
$499M
| $399K | 0.01% |
+17,652
| New | +$399K |
|
520
Axon Enterprise
AXON
$58.4B
| $392K | 0.01% |
982
| – | – |
|
521
Hormel Foods
HRL
$13.8B
| $389K | 0.01% |
12,272
+2,436
| +25% | +$77.2K |
|
522
Boston Properties
BXP
$11.5B
| $383K | 0.01% |
4,756
+812
| +21% | +$65.3K |
|
523
Loews
L
$20B
| $382K | 0.01% |
4,838
+812
| +20% | +$64.2K |
|
524
Fox Class A
FOXA
$27.2B
| $379K | 0.01% |
8,944
+1,624
| +22% | +$68.7K |
|
525
CarMax
KMX
$8.96B
| $374K | 0.01% |
4,837
+812
| +20% | +$62.8K |
|